Justin Hulvershorn

Justin Hulvershorn is an accomplished executive with a strong background in medical device innovation and research. Currently serving as CEO of Blink Device Company since January 2018, Justin oversees the marketing of the TwitchView train-of-four monitor for neuromuscular blockade management. Prior to this role, Justin was Chief Science Officer at Centurion Medical Products, where Justin contributed to the company's acquisition by Medline in 2017. Justin also founded Mirador Biomedical, which was acquired by Centurion, and held the position of Director of Research at Northstar Neuroscience before its acquisition by St Jude Medical. Justin holds an MD and a PhD in Biophysics from the University of Pennsylvania, and a BS in Engineering from the University of Virginia.